Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Cancer Res. 2009 Sep 8;69(18):7165–7169. doi: 10.1158/0008-5472.CAN-09-1448

Fig. 3. Elevated expression of miR-21 promotes enhanced tumor growth and castration-resistance in vivo.

Fig. 3

LNCaP miR-21 (black square) or a control vector (white circle) subcutaneous xenograft growth before and after castration. Castration was performed at ~ 375 mm3 tumor volume for each group. Tumor growth is normalized to the time of castration (day 0). Inset: Time course of tumor growth from the time of injection. Castration indicated by arrows. Mean ± S.E of at least 10 independent values. *P<0.05 (t-student test).

HHS Vulnerability Disclosure